Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
Julphar
Medtronic
Novartis
Citi
Daiichi Sankyo
Harvard Business School
Colorcon
Merck

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,767,851

« Back to Dashboard

Which drugs does patent 7,767,851 protect, and when does it expire?

Patent 7,767,851 protects AURYXIA and is included in one NDA.

This patent has seventy-two patent family members in twenty countries.
Summary for Patent: 7,767,851
Title:Ferric organic compounds, uses thereof and methods of making same
Abstract: The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.
Inventor(s): Kwok; David W. K. (Vancouver, CA), Stoynov; Nikolay Mintchev (Vancouver, CA)
Assignee: Panion & BF Biotech, Inc. (Nangang District, Taipei, TW)
Application Number:11/206,981
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound; Dosage form; Composition;

Drugs Protected by US Patent 7,767,851

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,767,851

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,093,423 Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same ➤ Try a Free Trial
8,609,896 Ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
9,050,316 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
8,754,257 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
8,846,976 Ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
9,328,133 Ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
8,901,349 Ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
8,754,258 Ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
8,299,298 Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same ➤ Try a Free Trial
9,757,416 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,767,851

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004213819 ➤ Try a Free Trial
Australia 2006279333 ➤ Try a Free Trial
Australia 2007210090 ➤ Try a Free Trial
Australia 2007210096 ➤ Try a Free Trial
Canada 2516471 ➤ Try a Free Trial
Canada 2619591 ➤ Try a Free Trial
Canada 2640763 ➤ Try a Free Trial
Canada 2640974 ➤ Try a Free Trial
China 100386336 ➤ Try a Free Trial
China 101253186 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Fish and Richardson
Merck
US Department of Justice
Medtronic
Dow
Teva
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot